Provider file · month-to-month premium

Henry Meds review (2026): the file, on record

ON RECORD · AUDIT QUEUEDUpdated August 17, 2026Field dictionary

Billing model: Month-to-month premium. This file runs on published rates — no one has re-walked this checkout this cycle, and the page says so wherever a number appears. The audited benchmark for the whole field is the NexLife file; every figure below should be read against it.

What it costs, on record

Henry publishes the field's cleanest no-commitment claim: compounded semaglutide near $149 a month and tirzepatide near $249, true month-to-month, with cancellation designed to be painless. Stay a full tirzepatide year and it totals near $2,988 — the premium is the standing cost of the open door.

Fits if — and watch for

Fits if you are new to the class, honest about the chance you stop early, and want quitting to be a click rather than a negotiation. Watch the year-one math if you end up staying anyway — past roughly month eight, committed rivals were the cheaper choice.

File status

Every figure above is an on-record published rate, filed in the open dataset with its source URL. An audit — a human re-walking the live checkout — converts this file's numbers to stamped figures or corrections; until then, under the site's iron rule, any audited competitor figure outranks these regardless of size. Compounded medications are not FDA-approved, and whether therapy fits you is a licensed clinician's call.

Open Henry Meds ↗ partner link, sponsored tag attached · how the money works